Skip to main content
AACIW logo

AACIW · Armada Acquisition Corp. III

Track AACIW — free
$0.15 0.00 (-0.13%) At close · Nov 17
Market Cap
$344.04M
Shares
34.03M
Volume · Nov 17 36.54K Avg daily vol (3M) 16.53K

Price & Indicators

 

Key stats

Close
$0.15
Tue 17 Nov
Open
$0.15
Tue 17 Nov
Average volume, 30 days
21K
shares a session
Short interest
7K
0.0% of shares · 1.4 days to cover
Day range
$0.15$0.15
Open $0.15 Close $0.15
Available closing range
$0.15$0.39
Close $0.15 61.3% under the high
Short volume, last session
97%
Latest filing
10-Q · Nov 13
Price history
Jul 2026 to Nov 2026

The closing range uses available history since Jul 24, 2026; less than a full year is stored.

Latest documents

2026
Nov 13
Quarterly report 10-Q Ended Sep 30
Substantial going concern doubt; $248,500,000 IPO closed

Armada Acquisition Corp. III reported net income of $2,923,560 for the nine months ended September 30, 2026, driven by $5,072,965 of Trust Account interest income. It closed its initial public offering of 24,850,000 units at $10.00 per unit on February 19, 2026, generating gross proceeds of $248,500,000. It has until August 19, 2027 to complete a business combination, and management has determined these conditions raise substantial doubt about its ability to continue as a going concern.

Read from the MD&A section
4 source passages
For the nine months ended September 30, 2026, we had a net income of $2,923,560, which consists of interest income on marketable securities held in the Trust Account of $5,072,965 offset by general and administrative costs of $1,919,778 and share-based compensation expense of $229,627. On February 19, 2026, we consummated the Initial Public Offering of 24,850,000 Units at $10.00 per Unit, which includes the partial exercise of the over-allotment option of 2,350,000 Units by the Underwriters, generating gross proceeds of $248,500,000. In connection with our assessment of going concern considerations in accordance with FASB ASC Topic 205-40, "Presentation of Financial Statements—Going Concern," we have until August 19, 2027 to consummate a Business Combination. We have determined that the liquidity condition and mandatory liquidation, should a Business Combination not occur, and potential subsequent dissolution raise substantial doubt about our ability to continue as a going concern. Open the document at this passage
Nov 5
Current report 8-K Events of Oct 31
Brains combination announced at $750.0 million enterprise value

Armada Acquisition Corp. III entered a Business Combination Agreement with Brains Bioceutical Corp. on October 31, 2026, valuing Brains at a $750.0 million enterprise value. The deal includes 14,705,882 earnout shares tied to $12.50 and $15.00 price targets.

Entered into a material agreement, Regulation FD disclosure Read from the first part of this long document
4 source passages
On October 31, 2026, Armada Acquisition Corp. III, a Cayman Islands exempted company (“SPAC”), entered into a Business Combination Agreement (the “Business Combination Agreement”) with Armada Sponsor III, LLC, a Delaware limited liability company (the “Sponsor”), Brains Bioceutical Corp., a company existing under the laws of British Columbia (“Brains” or the “Company,” which term, following the Amalgamation (as defined below), refers to the entity resulting from the Amalgamation), and Brains Therapeutics Corp., a company incorporated under the laws of British Columbia (“PubCo”). The aggregate consideration to be delivered to the security holders of Brains in connection with the Business Combination will consist of a number of newly issued PubCo Shares, Rollover Equity Awards and PubCo Rollover Warrants attributable to a transaction value equal to (A) $750.0 million (the “Enterprise Value”), minus (B) the Estimated Closing Balance Sheet Adjustment, minus (C) the excess of Company Expenses (if any) over $10.0 million, plus (D) the excess of SPAC Transaction Expenses (if any) over $10.0 million (such net amount, the “Transaction Value”), divided by $10.20 per share (the “Reference Value”). In addition, the Business Combination Agreement provides for 14,705,882 additional PubCo Shares (the “Earnout Shares”) to be issued to Company Shareholders at Closing and held in escrow, with one-half released upon the occurrence of a Tranche A Triggering Event and the remaining one-half upon a Tranche B Triggering Event during the period beginning six months after Closing and ending three years after Closing (the “Earnout Period”). A “Tranche A Triggering Event” occurs if the volume-weighted average price of PubCo Shares equals or exceeds $12.50 per share for at least 20 trading days within any consecutive 30-trading-day period during the Earnout Period, and a “Tranche B Triggering Event” occurs upon satisfaction of the same condition at $15.00 per share, in each case subject to adjustment for stock splits, stock dividends, reorganizations, recapitalizations and similar transactions after Closing. Open the document at this passage
All documents

Technicals

trend & momentum for long-term holders illustrative — not investment advice
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50/200-day averages unavailable
Institutional flow Distributing
-2% holders QoQ · +6 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
0.02% of shares out · ▲ +4.9% MoM · 1.4 days cover
Volume signal Reversal watch
High volume on a down day — possible exhaustion
Institution breadth Steady
55 holders — 13F breadth
Price context
position in its available closing range
Range low $0 Now $0 · 0% Range high $0
vs 50-day avg -38%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

KPI extraction has been attempted, but no publishable series is available from the examined filings. This is not evidence that the company reports no KPIs.

Versus peers

Shell Companies — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
AACIW
Armada Acquisition Corp. III
this stock
$344.04M — — — —
VYLR
Vylor Inc.
$45.22B — — — 2.1%
CLUS
Cluster Group Holdings Ltd Co
$8.00B — — — —
DMII
Drugs Made In America Acquisition II Corp.
$652.92M +3.5% — — 0.2%
BCSS
Bain Capital GSS Investment Corp.
$607.94M +3.3% — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
55
% held
99.9%
Net QoQ
+668.1K sh
Top holder
ADAGE CAPITAL PARTNERS GP…
Held Float
View
Held by Funds
Fund positions
2
View
Short & Settlement
Short Interest Rising
Shares short
7.0K
Days to cover
1.4d
Change
+328 sh
View
Short Volume
Short vol %
97%
As of
Nov 13, 2026
Short Total
View
Fails to Deliver
FTD shares
1
Value
$10
As of
Sep 25, 2026
View
Off-Exchange
Off-exchange %
36.7%
Week of
Oct 12, 2026
Off-exch Lit
View
Filings
SEC Filings
Latest
10-Q
Filed
Nov 13, 2026
This year
13

Armada Acquisition Corp. III reported net income of $2,923,560 for the nine months ended September 30, 2026, driven by $5,072,965 of Trust Account interest income. It closed its initial public offering of 24,850,000 units at $10.00 per unit on February 19, 2026, generating gross proceeds of $248,500,000. It has until August 19, 2027 to complete a business combination, and management has determined these conditions raise substantial doubt about its ability to continue as a going concern.

View
Earnings & Events
Investor Relations
Latest news
Armada Acquisition Corp. III and…
Published
Nov 5, 2026
View

Performance

5D 20D 120D MTD YTD
AACIW -14.0% -37.1% — -30.9% —
SPY -2.3% -4.8% -2.9% -3.1% +7.4%
vs SPY -11.6% -32.3% — -27.8% —
Key facts CIK 2092897 CUSIP G0R38M101 13F (30d) 41 filings 41 filers Visit website Investor relations